(Q58874460)
Statements
A multicenter, randomized, double-blind, placebo-controlled trial of long-term ascorbic acid treatment in Charcot-Marie-Tooth disease type 1A (CMT-TRIAAL): the study protocol [EudraCT no.: 2006-000032-27] (English)
Davide Pareyson
Angelo Schenone
Gian Maria Fabrizi
Franco Gemignani
Alessandra Solari
CMT-TRIAAL Group
9 September 2006